-
mAb anti-Human Hepatocellular Carcinoma
mAb anti-Human Hepatocellular Carcinoma
- 中文名称：
- mAb anti-Human Hepatocellular Carcinoma
- 英文名称：
- mAb anti-Human Hepatocellular Carcinoma
- 品牌：
- AAA Biotech
- 品牌介绍：
- AAA Biotech专注于为全球生命科学研究提供高品质的蛋白质研究工具，核心产品包括经严格验证的抗体、重组蛋白及ELISA试剂盒。
- 货号：
- AAA77895
- 规格：
- 0.1 mg|0.5 mg|2x0.5 mg|3x0.5 mg|4x0.5 mg
- 保存建议：
- Store at -20°C
- 货期：
- 6-8周
- 来源宿主：
- Mouse
- 反应种属：
- Human. Others not tested
There were no detectable positive reactions with other human tumor cell lines and solid tumour specimens. Showed negative reaction to all normal human adult tissues and fetal tissues tested.
- 应用：
- IF (Immunofluorescence)
- 免责声明：
- *本产品仅供科研实验使用，不得用于临床诊断。*
- 其他：
克隆性:Monoclonal
同型:IgG1,k
克隆号:[CHALV1]
特异性:Using indirect immunofluorescence assay, this MAb showed positive reactions with 8 human hepato-cellular carcinoma cell lines and 12 human liver cancer surgical specimens tested.
Hepatocellular Carcinoma
纯度:Protein G affinity purified
形式：Lyophilized from a solution in 0.01M PBS, pH7.0
浓度：N/A
- 说明书：
Mouse monoclonal antibody to human hapatocellular carcinoma.
Hepatocellular carcinoma frequently occurs in individuals infected with hepatitis virus B and/or C, and in alcoholic persons with cirrhosis. In countries where hepatitis is not epidemic, hepatocellular carcinoma is mostly metastatic cancers developed elsewhere in the body. At early stage, the cancer can be curable by surgical removal of small tumour if liver is in good condition or by transplantation if liver’s function is damaged because of disease. The cancer responds poorly to treatment at advanced stage.
